TBG Diagnostics Ltd represents values of innovation, integrity, and excellence in the diagnostics industry. As a leading provider of advanced diagnostic solutions, the company is committed to delivering accurate and reliable results to healthcare professionals and patients. With a focus on research and development, TBG Diagnostics Ltd strives to introduce innovative technologies that improve diagnostic capabilities and patient outcomes. The company's corporate philosophy is centered around customer satisfaction, operational efficiency, and continuous improvement. Through its dedication to quality and cutting-edge solutions, TBG Diagnostics Ltd aims to contribute to the advancement of healthcare globally.

TBG Diagnostics Ltd is primarily present in the Asia-Pacific region. This includes countries such as China, Japan, South Korea, Australia, and Singapore.

TBG Diagnostics Ltd has achieved several significant milestones in its company history. Notably, the company successfully developed and launched innovative diagnostic products that have made a profound impact on the healthcare industry. In addition, TBG Diagnostics Ltd expanded its global presence by establishing strategic partnerships with renowned medical institutions and securing regulatory approvals for its products in key markets. Through continuous research and development efforts, the company has consistently delivered advanced diagnostic solutions, ensuring accurate and reliable results for healthcare professionals and patients worldwide. TBG Diagnostics Ltd's commitment to innovation and quality has positioned it as a leading player in the diagnostic industry.

TBG Diagnostics Ltd. is a renowned company specializing in medical diagnostic products and systems. Founded in [insert year], the company has a rich history of innovation and steadfast commitment to advancing healthcare services. TBG Diagnostics Ltd. has gained significant recognition for its cutting-edge technologies and diagnostic solutions, catering to the evolving needs of healthcare professionals worldwide. With a strong focus on research and development, the company continuously strives to introduce pioneering products that revolutionize the field of diagnostics. TBG Diagnostics Ltd. has established itself as a trusted name in the industry, delivering accurate results and contributing to better patient outcomes.

The main competitors of TBG Diagnostics Ltd in the market are Bio-Rad Laboratories, Inc., Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific Inc., and Abbott Laboratories. These companies are also prominent players in the healthcare and diagnostics industry, offering a range of products and services similar to TBG Diagnostics Ltd. These competitors pose a significant challenge to TBG Diagnostics Ltd in terms of market share and innovation.

TBG Diagnostics Ltd primarily operates in the healthcare and medical diagnostics industry.

TBG Diagnostics Ltd is a company engaged in the business of providing diagnostic solutions and services. They specialize in developing and manufacturing in-vitro diagnostic products for the detection, monitoring, and management of a wide range of diseases and medical conditions. Their business model revolves around the research, development, and commercialization of innovative diagnostic technologies and products. By leveraging their expertise in molecular diagnostics, immunodiagnostics, and clinical chemistry, TBG Diagnostics aims to contribute to the improvement of global healthcare outcomes. With their focus on delivering high-quality and accurate diagnostic solutions, TBG Diagnostics Ltd positions itself as a reliable and trusted partner in the healthcare industry.

מכפיל הרווחים למניה של TBG Diagnostics הוא 0.

מכפיל המכירות של TBG Diagnostics הוא 0.32.

תוצאת איכות AlleAktien עבור TBG Diagnostics היא 5/10.

המחזור מצופה TBG Diagnostics הוא 182.76 מיליון AUD.

לא ניתן לחשב כרגע את הרווח עבור TBG Diagnostics.

TBG Diagnostics Ltd is a company specialized in the development, manufacturing, and marketing of medical diagnostic products and services. The company is divided into different business divisions that offer various products and services. The first business division of TBG Diagnostics Ltd is the production of clinical diagnostics. In this division, the company manufactures different products such as antibodies, enzymes, and antigens used in medical diagnostics. These products are sold to other companies that incorporate them into their own products. The second business division of TBG Diagnostics Ltd is the development and manufacturing of in vitro diagnostics (IVD). These products are used for diagnosing and monitoring diseases and conditions in patients. IVD products manufactured by TBG Diagnostics Ltd include blood glucose meters, urea test strips, pregnancy tests, and tests for infectious diseases such as HIV. Another business division of TBG Diagnostics Ltd is clinical trials. The company provides services in the field of clinical research and development of medical devices. It conducts clinical studies to test the effectiveness and safety of medical devices developed by other companies. TBG Diagnostics Ltd works closely with other companies to find medical solutions that ultimately benefit patients. In addition to these business divisions, TBG Diagnostics Ltd also offers other services. For example, the company provides consulting services to support customers in product development and marketing. It also offers training for customers to educate them on the use of TBG Diagnostics Ltd products and services and keep them informed about the latest developments in the medical sector. TBG Diagnostics Ltd's business model is based on the development and marketing of innovative medical diagnostic products and services. The company collaborates closely with other companies to develop medical products and services that improve patients' health. It is a leading provider of IVD products and clinical diagnostics sold worldwide. In a market characterized by rapid changes and technological innovation, TBG Diagnostics Ltd continually invests in research and development to ensure it keeps pace with the latest trends and developments in the medical sector. As a company specialized in the development of medical products and services for the healthcare sector, TBG Diagnostics Ltd is well-positioned to continue growing and succeeding in the future.

TBG Diagnostics מחלקת דיבידנד בסכום של 0 AUD במספר תשלומים במהלך השנה.

לא ניתן לחשב כרגע את הדיבידנד עבור TBG Diagnostics או שהחברה אינה מפרישה דיבידנד.

ISIN של TBG Diagnostics היא AU000000TDL4.

ה-WKN של TBG Diagnostics הוא A2AD8F.

הטיקר של TBG Diagnostics הוא TDL.AX.

במהלך 12 החודשים האחרונים, TBG Diagnostics שילמה דיבידנד בגובה . זה מקביל לתשואת דיבידנד של כ-. ל-12 החודשים הקרובים, TBG Diagnostics צפויה לשלם דיבידנד של 0 AUD.

תשואת הדיבידנד של TBG Diagnostics נוכחית היא .

TBG Diagnostics משלמת דיבידנד רבעוני. הדיבידנד מתבצע בחודשים .

TBG Diagnostics שילם דיבידנד כל שנה במשך ה-0 שנים האחרונות.

לתקופה הבאה של 12 חודשים ניתן לצפות לדיבידנדים בסך של 0 AUD. זה מייצג תשואת דיבידנד של 0 %.

TBG Diagnostics משויך למגזר 'בריאות'.

כדי לקבל את הדיבידנד האחרון של TBG Diagnostics מתאריך 27.9.2024 בסך 0 AUD, היה עליך להחזיק את המניה לפני היום המוקדם בתאריך 27.9.2024 בתיק.

תשלום הדיבידנד האחרון בוצע ב-27.9.2024.

בשנת 2023 שילמה TBG Diagnostics 0 AUD כדיבידנדים.

הדיבידנדים של TBG Diagnostics מתחלקים ב-AUD.